乳腺X线摄影中成组无定形钙化:常为不典型但罕见与侵袭性恶性肿瘤相关
本回顾性研究分析497个无定形钙化病灶的立体定向活检结果,总恶性率10.5%,其中侵袭性癌仅17/497(3.4%)且均为雌激素和孕激素受体阳性、淋巴结阴性。段样、线样或多组同象限分布的恶性率显著高于单组分布(28.6%、25.0%、25.0% vs 7.0%)。50岁以下无个人癌症史的成组无定形钙化恶性率低至3.1%(4/127)。
要点
- 无定形钙化总体恶性率10.5%(52/497),侵袭性癌仅3.4%(17/497)。
- 段样、线样或多组同象限分布恶性率显著高于单组分布(P=.004、.003、.002)。
- 50岁以下无癌症史的成组无定形钙化恶性率3.1%(4/127),但不典型率仍达30.7%。
核心结论
- 无定形钙化仍需活检,总体恶性率10.5%,但侵袭性癌少见(3.4%)且均为雌激素和孕激素受体阳性、淋巴结阴性;50岁以下无个人乳腺癌或卵巢癌史的成组无定形钙化恶性率低(3.1%)。
研究设计与样本
- 回顾性研究,2009年1月至2013年9月连续1903例立体定向活检中识别无定形钙化,最终纳入497个病灶(494例女性,中位年龄52岁,范围30-81岁),采用当前影像、临床和病理标准。
关键影像表现/征象
- 无定形钙化在乳腺X线摄影上表现为模糊、无定形钙化,分布可为单组、多组同象限、线样或段样。
- 52个恶性病灶中17个(42.7%)为侵袭性癌,中位大小0.3 cm(范围0.1-1.3 cm),均为雌激素和孕激素受体阳性且淋巴结阴性。
- 356个成组无定形钙化中102个(28.7%)活检结果为不典型而促使切除,其中3个(2.9%)切除后升级为导管原位癌。
诊断标准与关键数值
- 总恶性率10.5%(52/497,95%CI:7.9,13.5)。
- 段样分布恶性率28.6%(6/21),线样分布25.0%(8/32),多组同象限分布25.0%(9/36),均显著高于单组分布的7.0%(25/356)(P=.004、P=.003、P=.002)。
- 50岁以下无个人癌症史的成组无定形钙化恶性率3.1%(4/127,95%CI:0.9,7.9),最终组织学不典型率30.7%(39/127)。
临床应用与阅片要点
- 无定形钙化仍需立体定向活检,总体恶性率10.5%。
- 段样、线样或多组同象限分布的成组无定形钙化恶性率显著高于单组分布(28.6%、25.0%、25.0% vs 7.0%)。
- 50岁以下无乳腺癌或卵巢癌史的成组无定形钙化恶性率低(3.1%,4/127),但不典型率仍达30.7%(39/127)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To determine rate of malignancy at stereotactic biopsy of amorphous calcifications with different distributions using current imaging, clinical, and histopathologic criteria. Materials and Methods From January 2009 to September 2013, this retrospective study reviewed a large set of stereotactic biopsies to identify amorphous calcifications and their clinical, imaging, and histopathologic characteristics. Calcification distribution was correlated with malignancy rate after adjusting for known risk factors using logistic regression. Results Of 1903 sequential biopsies, 546 (28.7%) were for amorphous calcifications. After excluding atypical lesions not excised and patients with more than one biopsy in the same year, 497 lesions from 494 women (median age, 52 years; age range, 30-81 years) remained. Fifty-two (10.5%; 95% confidence interval [CI]: 7.9, 13.5) lesions proved malignant, with 17 of 52 (42.7%) being invasive cancers (median, 0.3 cm; range, 0.1-1.3 cm) and all 17 of them being estrogen and progesterone receptor positive and node negative. Malignancy rates in a segmental (six of 21 [28.6%]), linear (eight of 32 [25.0%]), or multiple group same quadrant (nine of 36 [25.0%]) distribution were significantly higher than malignancy rate in a solitary group of amorphous calcifications (25 of 356 [7.0%]) (P = .004, P = .003, and P = .002, respectively). Of 356 grouped amorphous calcifications, 102 (28.7%) yielded atypical results prompting excision, with three of 102 (2.9%) upgraded to ductal carcinoma in situ at excision. In women younger than 50 years without a personal history of cancer, grouped amorphous calcifications showed four of 127 (3.1%) (95% CI: 0.9, 7.9) were malignant and 39 of 127 (30.7%) were atypical at final histopathology. Conclusion Biopsy of amorphous calcifications remains necessary, with an overall malignancy rate of 10.5%; only 17 of 497 (3.4%) biopsies showed invasive cancer, and all of these were estrogen and progesterone receptor positive. Grouped amorphous calcifications in women younger than 50 years without history of breast or ovarian cancer showed a low malignancy rate of 3.1% (four of 127).
引用
- Oligane HC, Berg WA, Bandos AI, et al. Grouped Amorphous Calcifications at Mammography: Frequently Atypical but Rarely Associated with Aggressive Malignancy. Radiology. 2018. PMID: 29916773. doi:10.1148/radiol.2018172406
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。